Prescription products that are marketed as consumer products are known as Rx-to-OTC. They represent an important part of pharmaceutical strategy and a growing market. This report, The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available.
Patient-consumer awareness of health issues is driving the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the counter. An increased focus on cost-savings, coupled with the effects of advertising and promotion, result a higher rate of OTC purchases. Elderly baby boomers, are taking greater interest in their health, and growing the Rx-to-OTC industry in America.
Segments profiled in the report include:
Hair Loss Products
Analgesics, NSAIDs, and Pain Treatments
Cough, Cold, and Sinus Products
In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future and are in development. These products are listed.
Present revenues and past revenues for segment markets consist of the switched brands and OTC drugs containing switched ingredients. Five year forecasts are provided.
In addition to this information, the study tracks current issues and trends affecting the industry and identifies trends that may arise in the future. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers.The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures.
Search inside this report
Departmental Site License (one location, 10 users)